Loading...

Intellectia LogoIntellectia
AI Trading Bot
Features
Markets
News
Resources
Pricing
Get Started
  1. Home
  2. ETF
  3. LLY
LLY logo

LLY

-
$
0.000
0.000(0.000%)
At close
0.000(0.000%)Aft-market
ET
$
0.000
0.000(0.000%)
At close
0.000(0.000%)Aft-market
ET
OverviewTechnicalNews
an image of Intellectia Logoan image of Intellectia

Most Trusted AI Platform for Winning Trades

TwitterYoutubeQuoraDiscordLinkedinTelegram

Copyright © 2026 Intellectia.AI. All Rights Reserved.

Company

  • Home
  • Contact
  • About Us
  • Press
  • Privacy
  • Terms of Service
  • Service Terms of Use

Resources

  • Blog
  • Tutorial
  • Help Center
  • Affiliate Program

Markets

  • Market Analysis
  • Crypto
  • Featured Screeners
  • AI Earnings Calendar
  • Market Movers
  • Stock Monitor
  • Economic Calendar
  • All US Stocks
  • All Cryptos

Tools

  • Dividend Calculator
  • Dividend Yield Calculator
  • Options Profit Calculator

Features

  • QuantAI Alpha Pick
  • SwingMax Portfolio
  • Swing Trading
  • AI Stock Picker
  • Whales Auto Tracker
  • Daytrading Center
  • Patterns Detection
  • AI Screener
  • Financial AI Agent
  • Backtesting Playground
  • AI Earnings Prediction
  • Stock Monitor
  • Technical Analysis

News

  • Overview
  • Top News
  • Daily Market Brief
  • Earnings Analysis
  • Newswire
  • Stock News
  • Crypto News
  • Institution News
  • Congress News
  • Monitor News

Compare

  • TradingView
  • SeekingAlpha
Intellectia

LLY News

Eli Lilly's Strong Growth Potential Amid GLP-1 Focus

4d agoNASDAQ.COM

Novo Nordisk to Seek Approval for Weight-Loss Pill Soon

3d agoNewsfilter

Recap of CNBC Investing Club Monthly Meeting

2d agoCNBC

MoonLake Immunotherapeutics Set for Key Clinical Data Release

2d agostocktwits

Novo Nordisk to File for Wegovy Approval in China Soon

2d agoseekingalpha

Market Volatility and Portfolio Performance Overview

2d agoCNBC

Underrated Dividend Stocks with Low Yields

2d agoFool

Low Yield, High Growth Dividend Stocks

2d agoNASDAQ.COM

Market Momentum Broadens Beyond AI

2d agoCNBC

FDA Issues Warning Letters to Telehealth Firms Over Misleading GLP-1 Claims

2d agoseekingalpha

Pharmaceutical Industry Pressures Germany on Drug Pricing Policy

2d agoNewsfilter

Mixed Market on Tuesday as Tech Stocks Retreat After Strong Rally

3d agoCNBC

Analysis of Weight Loss Drug Market Prospects

3d agoFool

Eli Lilly and Novo Nordisk Compete in Weight Loss Market

3d agoNASDAQ.COM

Eli Lilly Acquires Pain Therapy Developer 4E Therapeutics

3d agoseekingalpha

Three Innovative Biotechs with Promising Prospects

3d agoNASDAQ.COM